MACKENZIE FINANCIAL CORP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$12,913,000
+20.8%
554,911
-17.3%
0.03%
+22.2%
Q1 2018$10,689,000
-9.6%
671,394
+18.0%
0.03%
-6.9%
Q4 2017$11,819,000
+537.5%
568,781
+339.6%
0.03%
+190.0%
Q3 2017$1,854,000
-17.2%
129,3980.0%0.01%
-16.7%
Q2 2017$2,239,000
+56.9%
129,3980.0%0.01%
+50.0%
Q1 2017$1,427,000
-85.1%
129,398
-80.4%
0.01%
-86.0%
Q4 2016$9,559,000
-52.9%
658,764
-20.3%
0.06%
-55.1%
Q3 2016$20,291,000
+15.4%
826,501
-5.3%
0.13%
+28.3%
Q2 2016$17,579,000
+30.8%
872,841
+70.8%
0.10%
-18.9%
Q1 2016$13,442,000
-9.0%
511,087
+247.9%
0.12%
+32.6%
Q4 2015$14,765,000
-93.3%
146,887
-88.0%
0.09%
-93.1%
Q3 2015$220,135,000
-20.1%
1,228,762
-0.4%
1.34%
-10.6%
Q2 2015$275,636,000
-11.7%
1,233,594
-21.9%
1.49%
-9.2%
Q1 2015$312,127,000
+30.6%
1,578,785
-5.6%
1.64%
+34.9%
Q4 2014$238,967,000
-5.3%
1,671,752
-13.3%
1.22%
-3.6%
Q3 2014$252,208,000
-4.8%
1,927,895
-8.0%
1.26%
+2.5%
Q2 2014$264,979,000
-7.6%
2,094,886
-3.8%
1.23%
-12.3%
Q1 2014$286,754,000
+5.0%
2,178,757
-6.5%
1.41%
+1.8%
Q4 2013$273,211,000
+11.7%
2,330,611
-0.6%
1.38%
+11.6%
Q3 2013$244,511,000
+11.7%
2,343,797
-7.7%
1.24%
+18.6%
Q2 2013$218,995,0002,538,4361.04%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders